title: A short half-life of the administered factor XIII (FXIII) concentrates after the first replacement therapy in a newborn with severe congenital FXIII deficiency.
authors.forename: Noriko
authors.initials: N
authors.lastname: Fujii
authors.forename: Masayoshi
authors.initials: M
authors.lastname: Souri
authors.forename: Akitada
authors.initials: A
authors.lastname: Ichinose
mesh_terms: D018450:Disease Progression; D056947:Enzyme Replacement Therapy; D005176:Factor XIII / Q000008:administration & dosage / Q000737:chemistry / Q000493:pharmacokinetics*; D005177:Factor XIII Deficiency / Q000150:complications / Q000151:congenital / Q000188:drug therapy* / Q000503:physiopathology; D006207:Half-Life; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D007231:Infant, Newborn; D007564:Japan; D008297:Male; D012008:Recurrence; D013997:Time Factors; D014470:Umbilical Cord / Q000473:pathology
chemical_list: D005176:Factor XIII